Cargando…
936. Risk Factors and Clinical Outcomes for Extended-Spectrum Beta-Lactamase Producing Enterobacterales Blood Stream Infections in Patients with Hematologic Malignancies
BACKGROUND: Hematologic malignancy patients have high rates of antibiotic exposure, and increasing resistance is a major concern, particularly with extended-spectrum beta lactamases (ESBL) in Enterobacterales blood stream infections (BSIs). Identifying risk factors for ESBL-producing Enterobacterale...
Autores principales: | Lefemine, Amanda, Meredith, Jacqueline, Hammer, Katie, Kachur, Ekaterina, He, Jiaxian, Speight, Carly C, shahid, zainab |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643806/ http://dx.doi.org/10.1093/ofid/ofab466.1131 |
Ejemplares similares
-
Reviving the role of mecillinam against extended spectrum beta-lactamase producing enterobacterales
por: Kaleem, Fatima, et al.
Publicado: (2022) -
Colonization dynamics of extended-spectrum beta-lactamase-producing Enterobacterales in the gut of Malawian adults
por: Lewis, Joseph M., et al.
Publicado: (2022) -
Fecal carriage of extended-spectrum beta-lactamase-producing Enterobacterales in healthy Spanish schoolchildren
por: López-Siles, Mireia, et al.
Publicado: (2023) -
Treatment duration of complicated urinary tract infections by extended-spectrum beta-lactamases producing enterobacterales
por: Álvarez Otero, Judith, et al.
Publicado: (2020) -
Detection of colonisation by extended-spectrum beta-lactamase or carbapenemase producing Enterobacterales from frozen stool specimens
por: Tan, Pisey, et al.
Publicado: (2020)